Axonics Modulation Technologies
Why Robinhood?
You can watch AXNX and buy or sell other stocks, ETFs, and their options commission-free!About AXNX
Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women.
AXNX Key Statistics
Stock Snapshot
As of today, Axonics Modulation Technologies(AXNX) shares are valued at $70.98. The company's market cap stands at 3.63B, with a P/E ratio of -657.22.
On 2026-08-07, Axonics Modulation Technologies(AXNX) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Axonics Modulation Technologies(AXNX) stock has reached 0.
The stock's 52-week range extends from a low of $55.09 to a high of $71.05.
The stock's 52-week range extends from a low of $55.09 to a high of $71.05.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.